Benign course in multiple sclerosis: a review

被引:93
作者
Ramsaransing, GSM [1 ]
De Keyser, J [1 ]
机构
[1] Univ Groningen, Med Ctr, Dept Neurol, Groningen, Netherlands
来源
ACTA NEUROLOGICA SCANDINAVICA | 2006年 / 113卷 / 06期
关键词
multiple sclerosis; benign; disease course; disability;
D O I
10.1111/j.1600-0404.2006.00637.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Since the 1950s, it has been recognized that a subgroup of multiple sclerosis (MS) patients exists that shows little or no progression in the severity of the disease over time. This group is referred to as 'benign' MS. Although a substantial amount of research in MS indicates a multifactorial background in disease severity, to date it is still difficult to predict whether the course will be benign at onset and it is difficult to find factors that influence the course of the disease over time. Maintaining or restoring neural conduction inside a central nervous system lesion seems to be the essence of staying 'benign'.
引用
收藏
页码:359 / 369
页数:11
相关论文
共 119 条
[1]   A prospective study on the prognosis of multiple sclerosis [J].
M.P. Amato ;
G. Ponziani .
Neurological Sciences, 2000, 21 (Suppl 2) :S831-S838
[2]   A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials [J].
Amato, MP ;
Ponziani, G ;
Bartolozzi, ML ;
Siracusa, G .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 168 (02) :96-106
[3]   Multiple sclerosis that is progressive from the time of onset -: Clinical characteristics and progression of disability [J].
Andersson, PB ;
Waubant, E ;
Gee, L ;
Goodkin, DE .
ARCHIVES OF NEUROLOGY, 1999, 56 (09) :1138-1142
[4]   Mitochondrial dysfunction plays a key role in progressive axonal loss in multiple sclerosis [J].
Andrews, HE ;
Nichols, PP ;
Bates, D ;
Turnbull, DM .
MEDICAL HYPOTHESES, 2005, 64 (04) :669-677
[5]   Molecular pathogenesis of multiple sclerosis [J].
Bar-Or, A ;
Oliveira, EML ;
Anderson, DE ;
Hafler, DA .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 100 (1-2) :252-259
[6]   HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course [J].
Barcellos, LF ;
Oksenberg, JR ;
Begovich, AB ;
Martin, ER ;
Schmidt, S ;
Vittinghoff, E ;
Goodin, DS ;
Pelletier, D ;
Lincoln, RR ;
Bucher, P ;
Swerdlin, A ;
Perick-Vance, MA ;
Haines, JL ;
Hauser, SL .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (03) :710-716
[7]   THE LONGSTANDING MS LESION - A QUANTITATIVE MRI AND ELECTRON-MICROSCOPIC STUDY [J].
BARNES, D ;
MUNRO, PMG ;
YOUL, BD ;
PRINEAS, JW ;
MCDONALD, WI .
BRAIN, 1991, 114 :1271-1280
[8]  
BAUER HF, 1965, ANN NY ACAD SCI, V122, P542
[9]   The natural history of untreated multiple sclerosis in Iceland.: A total population-based 50 year prospective study [J].
Benedikz, J ;
Stefánsson, M ;
Guomundsson, J ;
Jónasdóttir, A ;
Fossdal, R ;
Gulcher, J ;
Stefánsson, K .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2002, 104 (03) :208-210
[10]   Predicting secondary progression in relapsing-remitting multiple sclerosis: a Bayesian analysis [J].
Bergamaschi, R ;
Berzuini, C ;
Romani, A ;
Cosi, V .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 189 (1-2) :13-21